Skip to main content
Beth Israel Deaconess Medical Center Harvard Medical School Teaching Hospital
Rebecca Luckett
Primary menu
  • Home
  • Team
  • Research
  • Publications
  1. Home
  2. Publications
  3. Will HPV vaccination affect cervical cancer morbidity and mortality world-wide?

Will HPV vaccination affect cervical cancer morbidity and mortality world-wide?

Luckett, Rebecca, and Sarah Feldman. 2016. “Will HPV Vaccination Affect Cervical Cancer Morbidity and Mortality World-Wide?”. Human Vaccines & Immunotherapeutics 12 (6): 1373-4.
Publisher's Version
Last updated on 07/02/2026
PubMed

Recent Publications

  • Individual-level HPV vaccination verification in Botswana: lessons learned from implementation of the HOPE II trial.
  • Pre-Eclampsia Rates in Women With and Without HIV in Modern ART Era in Botswana.
  • Prevalence of depression and association with quality-of-life among oncology patients at Princess Marina Hospital, Botswana: A cross-sectional study.
  • Persistent or recurrent cervical dysplasia in women living with HIV after treatment for high-grade dysplasia in Botswana.
  • Understanding barriers to cervical cancer screening in Botswana: Insights from a cross-sectional study.
  • Cervical dysplasia in women with HIV in the modern treat-all era: elevated risk remains despite long-term ART and normal CD4 + cell count.

Share

Contact

Rebecca Luckett, MD, PhD, MPH
Beth Israel Deaconess Medical Center 
330 Brookline Ave 
Boston, MA 02215 
rluckett@bidmc.harvard.edu

Secondary menu

Follow Me

  • LinkedIn

Harvard Catalyst

Powered byOpenScholar®Admin Login
Beth Israel Deaconess Medical Center Harvard Medical School Teaching Hospital